News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
The OpenSea App is now officially available for public download.
OpenSea co-founder and CEO Devin Finzer has announced that the OpenSea App is officially available for public download starting today. This version fully integrates three core functions: it aggregates the trader social graphs and trading activity scattered across platforms such as FOMO, Pump, and Farcaster, allowing users to track on-chain operations in real time within the activity feed and claim their personal profiles; it also supports convenient deposits via Apple Pay to create or import an existing wallet, enabling a single account to track assets across wallets and trade tokens, Memes, NFT artworks, and trading cards with one click; at the same time, trade execution is underpinned by cross-chain liquidity and real-time pricing. Finzer stated that the current version is at a foundational aggregation stage, and more precise customized trading signals and on-chain performance profiles will continue to be launched in the future.
Israel's defense minister again threatens to occupy more Lebanese territory.
According to a CoinWorld report, Israeli Defense Minister Katz said on the 20th that if Hezbollah in Lebanon participates in Iran's attack on Israel, the Israeli military will occupy more Lebanese territory.
The National Bureau of Statistics released the unemployment rate data by age group for September 2026.
BiJie Network data: The National Bureau of Statistics released unemployment rate data by age group for September 2026. In September, the national urban surveyed unemployment rate was 5.2%, the national urban unemployment rate for the 16-24 age group was 18%, the unemployment rate for the 25-29 age group was 7.4%, and the unemployment rate for the 30-59 age group was 3.9%.
AAVE v4 received $10.1 million in Coinbase tokenized stock deposits, accounting for 53%.
According to CoinWorld news, AAVE v4 on the Base chain has absorbed approximately $10.1 million in Coinbase tokenized stock deposits, accounting for 53% of the roughly $18.9 million in total deposits of such assets across DeFi platforms. AAVE v4 ranks first among DeFi platforms by total value locked for this asset class.
A certain user made a profit of $282,000 within 2 hours, a return rate of 332 times.
According to a report from Bijie, data from Lookonchain shows that a user realized a profit of $282,000 in just 2 hours, with a return rate as high as 332x. Two hours ago, he spent 8 SOL (about $848) to buy 9.91 million $KIMCHI, and then sold 4.88 million $KIMCHI for 1,045 SOL (about $111,000). He currently still holds 5.03 million $KIMCHI, worth about $171,000, for a total profit of $282,000.
U.S. Commerce Secretary announces semiconductor investment in North Carolina
CoinWorld news, U.S. Commerce Secretary Lutnick announced on Tuesday that industrial mineral mining and processing company Sibelco will make a new investment in North Carolina to support semiconductor production. He said Sibelco will establish a silicon manufacturing facility, specifically quartz manufacturing, which is basically the cornerstone of the semiconductor industry. Although he did not disclose specific details, he said the investment would be in the "hundreds of millions of dollars" range.
VIX收报17.31点，VXN收报25.22点
CoinWorld US stock data: End-of-day data shows that on the 2026-10-20 trading day, VIX closed at 17.31 points and VXN closed at 25.22 points.
BTC liquidations totaled $74.97 million over the past 24 hours.
According to data from Bijie.com, the rolling 24-hour liquidation amount for BTC is approximately 74.9701 million USD, involving about 3,939 liquidated accounts. Compared with the same-caliber snapshot 24 hours earlier, it is up 123.09%; compared with the same-caliber snapshot 7 days earlier, it is up 32.81%.